BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2017 7:10:38 AM | Browse: 1321 | Download: 2053
 |
Received |
|
2017-07-31 00:19 |
 |
Peer-Review Started |
|
2017-07-31 00:59 |
 |
To Make the First Decision |
|
2017-08-15 03:40 |
 |
Return for Revision |
|
2017-08-16 09:27 |
 |
Revised |
|
2017-09-08 11:23 |
 |
Second Decision |
|
2017-09-15 00:06 |
 |
Accepted by Journal Editor-in-Chief |
|
2017-09-15 16:06 |
 |
Accepted by Executive Editor-in-Chief |
|
2017-09-19 20:53 |
 |
Articles in Press |
|
2017-09-19 20:53 |
 |
Publication Fee Transferred |
|
2017-09-21 06:29 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2017-10-18 03:03 |
 |
Publish the Manuscript Online |
|
2017-10-21 07:10 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Case Report |
Article Title |
Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Perttu Lahtinen, Eero Mattila, Veli-Jukka Anttila, Jyrki Tillonen, Matti Teittinen, Pasi Nevalainen, Seppo Salminen, Reetta Satokari and Perttu Arkkila |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Perttu Lahtinen, MD, Department of Gastroenterology, Päijät-Häme Central Hospital, Keskussairaalankatu 7, Lahti 15610, Finland. perttupaavali@gmail.com |
Key Words |
Faecal microbiota transplantation; Antibiotic resistance; Clostridium difficile infection; Microbiota; Immunodeficiency; Salmonella infection |
Core Tip |
Knowledge of faecal microbiota transplantation (FMT) in immunocompromised patients and patients with conditions other than recurrent Clostridium difficile infection (rCDI) is scarce. We reviewed 13 FMT-treated patients with rCDI and major comorbidities as well as 8 patients with new indications. In our cohort, FMT appeared to be safe and effective for immunocompromised patients: dialysis patients, human immunodeficiency virus patients, solid organ transplant patients and a patient with chronic lymphatic leukaemia. Of the patients treated for indications other than rCDI, the most promising results were successful eradication of antibiotic-resistant bacteria. Eradication of chronic Salmonella carriage in two patients with FMT represents the first cases reported to date. |
Publish Date |
2017-10-21 07:10 |
Citation |
Lahtinen P, Mattila E, Anttila VJ, Tillonen J, Teittinen M, Nevalainen P, Salminen S, Satokari R, Arkkila P. Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series. World J Gastroenterol 2017; 23(39): 7174-7184 |
URL |
http://www.wjgnet.com/1007-9327/full/v23/i39/7174.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v23.i39.7174 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345